• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Studies of 99mTc-BnAO (HL-91): a non-nitroaromatic compound for hypoxic cell detection.

作者信息

Zhang X, Melo T, Ballinger J R, Rauth A M

机构信息

Division of Experimental Therapeutics, Ontario Cancer Institute, Toronto, Canada.

出版信息

Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):737-40. doi: 10.1016/s0360-3016(98)00301-0.

DOI:10.1016/s0360-3016(98)00301-0
PMID:9845087
Abstract

PURPOSE

Solid tumours of similar type and stage can vary widely in their hypoxic cell fraction. Such cells may be prognostic for aggressive, metastatic, and radiation-resistant disease. A 99mtechnetium (99mTc)-labelled non-nitroaromatic agent, butyleneamine oxime (99mTc-BnAO) or HL-91 (Amersham International, Inc., Amersham, UK) has been evaluated both in vitro and in vivo for its possible efficacy as a noninvasive marker for the clinical detection of hypoxic cells in solid tumours.

MATERIALS AND METHODS

Suspension cultures of Chinese hamster ovary (CHO) cells under controlled levels of oxygen were used to measure the oxygen dependency of 99mTc-BnAO accumulation. V79 cells grown as multilayers on a semipermeable membrane served as an in vitro model for drug penetration through the extravascular space of the tumour. C3H mice bearing KHT-C leg tumours were the in vivo models for selective drug accumulation as a function of time after i.v. administration of 99mTc-BnAO.

RESULTS

99mTc accumulated selectively in hypoxic vs. aerobic cells, resulting in a 9 +/- 2-fold differential in radioactivity per cell at 4 h. The k(m) for this selective accumulation was 20 ppm of oxygen. The labelled drug was equally effective in penetrating the cellular multilayer under aerobic or hypoxic conditions. In vivo measurements indicated favourable labelling of solid tumours containing hypoxic cells with 1% of the total activity per g of tumour, a tumour-to-blood ratio of 1.2, and a tumour-to-muscle ratio of 4.6 at 4 to 6 h after drug administration. In contrast to more lipophilic 99mTc- labelled compounds, excretion was primarily via the urinary tract. Nitro-L-arginine selectively increased solid tumour labelling over normal tissue.

CONCLUSIONS

99mTc-BnAO or HL-91 is a promising agent for clinical studies of tumour hypoxia, although the mechanism of its selective hypoxic cell accumulation remains unexplained.

摘要

相似文献

1
Studies of 99mTc-BnAO (HL-91): a non-nitroaromatic compound for hypoxic cell detection.
Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):737-40. doi: 10.1016/s0360-3016(98)00301-0.
2
In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia.
J Nucl Med. 1996 Jun;37(6):1023-31.
3
Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo.
Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):731-5. doi: 10.1016/s0360-3016(98)00300-9.
4
Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models.
Nucl Med Commun. 2003 May;24(5):597-606. doi: 10.1097/00006231-200305000-00017.
5
BRU59-21, a second-generation 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors.BRU59-21,一种用于肿瘤缺氧成像的第二代99mTc标记的2-硝基咪唑。
J Nucl Med. 2000 Jan;41(1):169-76.
6
Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid.缺氧标志物(99m)锝标记的2,2'-(1,4-二氨基丁烷)双(2-甲基-3-丁酮)二肟(99mTc标记的HL-91;Prognox)的闪烁成像:对血管生成抑制剂5,6-二甲基氧杂蒽-4-乙酸的肿瘤反应的无创检测
Cancer Res. 2000 Aug 15;60(16):4582-8.
7
Cellular accumulation and retention of the technetium-99m-labelled hypoxia markers BRU59-21 and butylene amine oxime.锝-99m标记的缺氧标志物BRU59-21和丁烯胺肟的细胞积聚与滞留
Nucl Med Biol. 2001 Nov;28(8):949-57. doi: 10.1016/s0969-8051(01)00267-0.
8
Anti-angiogenic therapy and chemotherapy affect 99mTc sestamibi and 99mTc-HL91 accumulation differently in tumour xenografts.
Nucl Med Commun. 2005 Dec;26(12):1067-73. doi: 10.1097/00006231-200512000-00004.
9
The biological characterization of (99m)Tc-BnAO-NI as a SPECT probe for imaging hypoxia in a sarcoma-bearing mouse model.(99m)Tc-BnAO-NI作为一种用于荷肉瘤小鼠模型缺氧成像的单光子发射计算机断层扫描(SPECT)探针的生物学特性研究。
Appl Radiat Isot. 2011 Apr;69(4):649-55. doi: 10.1016/j.apradiso.2010.12.009. Epub 2010 Dec 25.
10
Labelling, control and radiopharmacological evaluation of 99mTc-adenosine 5'-diphosphate (99mTc-ADP) as tumour seeking agent.99mTc - 腺苷5'-二磷酸(99mTc - ADP)作为肿瘤寻靶剂的标记、质控及放射性药物评价
Q J Nucl Med. 1996 Jun;40(2):170-5.

引用本文的文献

1
Oxygen Sensing, Hypoxia Tracing and Imaging with Functional Metalloprobes for the Early Detection of Non-communicable Diseases.用于非传染性疾病早期检测的功能性金属探针的氧传感、缺氧追踪与成像
Front Chem. 2018 Feb 23;6:27. doi: 10.3389/fchem.2018.00027. eCollection 2018.
2
Molecular Imaging of Hypoxia: Strategies for Probe Design and Application.缺氧的分子成像:探针设计与应用策略
Curr Org Synth. 2011 Aug;8(4):593-603. doi: 10.2174/157017911796117179.
3
The tumor microenvironment in non-small-cell lung cancer.非小细胞肺癌的肿瘤微环境。
Semin Radiat Oncol. 2010 Jul;20(3):156-63. doi: 10.1016/j.semradonc.2010.01.003.
4
Molecular imaging of hypoxia with radiolabelled agents.用放射性标记剂对缺氧进行分子成像。
Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1674-86. doi: 10.1007/s00259-009-1195-9. Epub 2009 Jun 30.
5
Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET.用于正电子发射断层扫描(PET)治疗监测的临床前和临床开发阶段的放射性药物。
J Nucl Med. 2009 May;50 Suppl 1(Suppl 1):106S-21S. doi: 10.2967/jnumed.108.057281. Epub 2009 Apr 20.
6
Accumulation of Tc-99m HL91 in tumor hypoxia: in vitro cell culture and in vivo tumor model.锝-99m HL91在肿瘤缺氧区域的积聚:体外细胞培养和体内肿瘤模型
Kaohsiung J Med Sci. 2008 Sep;24(9):461-72. doi: 10.1016/S1607-551X(09)70003-8.
7
Targeted molecular imaging in oncology: focus on radiation therapy.肿瘤学中的靶向分子成像:聚焦于放射治疗。
Semin Radiat Oncol. 2008 Apr;18(2):136-48. doi: 10.1016/j.semradonc.2007.10.009.